Bortezomib

Bortezomib targets …TARGETS15 of 38show all (up to 200)
→ targets	SEM1	—	INHIBITOR	—	1	Curated	chembl	graph →
→ targets	PSMD4	—	INHIBITOR	—	1	Curated	chembl	graph →
→ targets	PSMD8	—	INHIBITOR	—	1	Curated	chembl	graph →
→ targets	PSMD13	—	INHIBITOR	—	1	Curated	chembl	graph →
→ targets	PSMD6	—	INHIBITOR	—	1	Curated	chembl	graph →
→ targets	PSMD7	—	INHIBITOR	—	1	Curated	chembl	graph →
→ targets	PSMD11	—	INHIBITOR	—	1	Curated	chembl	graph →
→ targets	PSMD2	—	INHIBITOR	—	1	Curated	chembl	graph →
→ targets	PSMD3	—	INHIBITOR	—	1	Curated	chembl	graph →
→ targets	PSMD12	—	INHIBITOR	—	1	Curated	chembl	graph →
→ targets	PSMC3	—	INHIBITOR	—	1	Curated	chembl	graph →
→ targets	PSMC5	—	INHIBITOR	—	1	Curated	chembl	graph →
→ targets	PSMC6	—	INHIBITOR	—	1	Curated	chembl	graph →
→ targets	PSMC1	—	INHIBITOR	—	1	Curated	chembl	graph →
→ targets	PSMC2	—	INHIBITOR	—	1	Curated	chembl	graph →

Bortezomib targets …TARGETS15 of 38show all (up to 200)

→ targets

SEM1

—

INHIBITOR

—

Curated

→ targets

PSMD4

—

INHIBITOR

—

Curated

→ targets

PSMD8

—

INHIBITOR

—

Curated

→ targets

PSMD13

—

INHIBITOR

—

Curated

→ targets

PSMD6

—

INHIBITOR

—

Curated

→ targets

PSMD7

—

INHIBITOR

—

Curated

→ targets

PSMD11

—

INHIBITOR

—

Curated

→ targets

PSMD2

—

INHIBITOR

—

Curated

→ targets

PSMD3

—

INHIBITOR

—

Curated

→ targets

PSMD12

—

INHIBITOR

—

Curated

→ targets

PSMC3

—

INHIBITOR

—

Curated

→ targets

PSMC5

—

INHIBITOR

—

Curated

→ targets

PSMC6

—

INHIBITOR

—

Curated

→ targets

PSMC1

—

INHIBITOR

—

Curated

→ targets

PSMC2

—

INHIBITOR

—

Curated

Bortezomib investigated for …INVESTIGATED_FOR75 of 75show fewer
→ investigated for	Mantle Cell Lymphomahematologic_malignancy	unknown	4	Mantle Cell Lymphoma	1	Curated	chembl	graph →
→ investigated for	Neoplasmcancer_family	unknown	4	Neoplasm	1	Curated	chembl	graph →
→ investigated for	Multiple Myelomahematologic_malignancy	unknown	4	Multiple Myeloma	1	Curated	chembl	graph →
→ investigated for	T Acute Lymphoblastic Leukemiahematologic_malignancy	unknown	3	T Acute Lymphoblastic Leukemia	1	Curated	chembl	graph →
→ investigated for	AL Amyloidosishematologic_malignancy	unknown	3	AL Amyloidosis	1	Curated	chembl	graph →
→ investigated for	Cholangiocarcinomasubtype	unknown	3	Cholangiocarcinoma	1	Curated	chembl	graph →
→ investigated for	Waldenstrom Macroglobulinemiahematologic_malignancy	unknown	3	Waldenstrom Macroglobulinemia	1	Curated	chembl	graph →
→ investigated for	Myeloid Sarcomacancer_family	unknown	3	Myeloid Sarcoma	1	Curated	chembl	graph →
→ investigated for	Non-Hodgkin Lymphomahematologic_malignancy	unknown	3	Non-Hodgkin Lymphoma	1	Curated	chembl	graph →
→ investigated for	Plasmacytomahematologic_malignancy	unknown	3	Plasmacytoma	1	Curated	chembl	graph →
→ investigated for	Acute Lymphoblastic Leukemiahematologic_malignancy	unknown	3	Acute Lymphoblastic Leukemia	1	Curated	chembl	graph →
→ investigated for	Acute Myeloid Leukemiahematologic_malignancy	unknown	3	Acute Myeloid Leukemia	1	Curated	chembl	graph →
→ investigated for	Lymphomacancer_family	unknown	3	Lymphoma	1	Curated	chembl	graph →
→ investigated for	Leukemiacancer_family	unknown	3	Leukemia	1	Curated	chembl	graph →
→ investigated for	Lung Adenocarcinomasubtype	supports	D	Lung Adenocarcinoma	1	Curated	civic	graph →
→ investigated for	Cervical Neoplasmsubtype	unknown	2	Cervical Neoplasm	1	Curated	chembl	graph →
→ investigated for	Minimally Invasive Lung Adenocarcinomasubtype	unknown	2	Minimally Invasive Lung Adenocarcinoma	1	Curated	chembl	graph →
→ investigated for	Nasopharyngeal Carcinomasubtype	unknown	2	Nasopharyngeal Carcinoma	1	Curated	chembl	graph →
→ investigated for	Uveal Melanomasubtype	unknown	2	Uveal Melanoma	1	Curated	chembl	graph →
→ investigated for	Colorectal Neoplasmsubtype	unknown	2	Colorectal Neoplasm	1	Curated	chembl	graph →
→ investigated for	Liver Neoplasmsubtype	unknown	2	Liver Neoplasm	1	Curated	chembl	graph →
→ investigated for	Paragangliomasubtype	unknown	2	Paraganglioma	1	Curated	chembl	graph →
→ investigated for	Plasma Cell Neoplasmhematologic_malignancy	unknown	2	Plasma Cell Neoplasm	1	Curated	chembl	graph →
→ investigated for	Lung Neoplasmcancer_family	unknown	2	Lung Neoplasm	1	Curated	chembl	graph →
→ investigated for	Ureter Neoplasmsubtype	unknown	2	Ureter Neoplasm	1	Curated	chembl	graph →
→ investigated for	Breast Neoplasmcancer_family	unknown	2	Breast Neoplasm	1	Curated	chembl	graph →
→ investigated for	Esophageal Neoplasmcancer_family	unknown	2	Esophageal Neoplasm	1	Curated	chembl	graph →
→ investigated for	Ovarian Neoplasmsubtype	unknown	2	Ovarian Neoplasm	1	Curated	chembl	graph →
→ investigated for	Kidney Neoplasmsubtype	unknown	2	Kidney Neoplasm	1	Curated	chembl	graph →
→ investigated for	Urethra Neoplasmsubtype	unknown	2	Urethra Neoplasm	1	Curated	chembl	graph →
→ investigated for	Gastric Neoplasmcancer_family	unknown	2	Gastric Neoplasm	1	Curated	chembl	graph →
→ investigated for	Bladder Neoplasmsubtype	unknown	2	Bladder Neoplasm	1	Curated	chembl	graph →
→ investigated for	Central Nervous System Neoplasmcancer_family	unknown	2	Central Nervous System Neoplasm	1	Curated	chembl	graph →
→ investigated for	Lung Adenocarcinomasubtype	unknown	2	Lung Adenocarcinoma	1	Curated	chembl	graph →
→ investigated for	Head and Neck Neoplasmcancer_family	unknown	2	Head and Neck Neoplasm	1	Curated	chembl	graph →
→ investigated for	Gliosarcomasubtype	unknown	2	Gliosarcoma	1	Curated	chembl	graph →
→ investigated for	Plasma Cell Leukemiahematologic_malignancy	unknown	2	Plasma Cell Leukemia	1	Curated	chembl	graph →
→ investigated for	Nasopharyngeal Neoplasmsubtype	unknown	2	Nasopharyngeal Neoplasm	1	Curated	chembl	graph →
→ investigated for	Pancreatic Neoplasmsubtype	unknown	2	Pancreatic Neoplasm	1	Curated	chembl	graph →
→ investigated for	Prostate Neoplasmsubtype	unknown	2	Prostate Neoplasm	1	Curated	chembl	graph →
→ investigated for	Hematopoietic and Lymphoid Cell Neoplasmcancer_family	unknown	2	Hematopoietic and Lymphoid Cell Neoplasm	1	Curated	chembl	graph →
→ investigated for	Sarcomacancer_family	unknown	2	Sarcoma	1	Curated	chembl	graph →
→ investigated for	Glioblastomasubtype	unknown	2	Glioblastoma	1	Curated	chembl	graph →
→ investigated for	Thyroid Gland Neoplasmsubtype	unknown	2	Thyroid Gland Neoplasm	1	Curated	chembl	graph →
→ investigated for	Thyroid Gland Follicular Carcinomacancer_family	unknown	2	Thyroid Gland Follicular Carcinoma	1	Curated	chembl	graph →
→ investigated for	Adenoid Cystic Carcinomahistology	unknown	2	Adenoid Cystic Carcinoma	1	Curated	chembl	graph →
→ investigated for	Chronic Myeloid Leukemia, BCR-ABL1 Positivemolecular_subtype	unknown	2	Chronic Myeloid Leukemia, BCR-ABL1 Positive	1	Curated	chembl	graph →
→ investigated for	Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissuehematologic_malignancy	unknown	2	Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue	1	Curated	chembl	graph →
→ investigated for	Peripheral T-Cell Lymphoma, Not Otherwise Specifiedhematologic_malignancy	unknown	2	Peripheral T-Cell Lymphoma, Not Otherwise Specified	1	Curated	chembl	graph →
→ investigated for	Hodgkin Lymphomahematologic_malignancy	unknown	2	Hodgkin Lymphoma	1	Curated	chembl	graph →
→ investigated for	Chronic Lymphocytic Leukemiahematologic_malignancy	unknown	2	Chronic Lymphocytic Leukemia	1	Curated	chembl	graph →
→ investigated for	Acute Biphenotypic Leukemiahematologic_malignancy	unknown	2	Acute Biphenotypic Leukemia	1	Curated	chembl	graph →
→ investigated for	Lung Non-Small Cell Carcinomasubtype	unknown	2	Lung Non-Small Cell Carcinoma	1	Curated	chembl	graph →
→ investigated for	Malignant Mesotheliomacancer_family	unknown	2	Malignant Mesothelioma	1	Curated	chembl	graph →
→ investigated for	Follicular Lymphomahematologic_malignancy	unknown	2	Follicular Lymphoma	1	Curated	chembl	graph →
→ investigated for	Acute Promyelocytic Leukemiahematologic_malignancy	unknown	2	Acute Promyelocytic Leukemia	1	Curated	chembl	graph →
→ investigated for	Melanomacancer_family	unknown	2	Melanoma	1	Curated	chembl	graph →
→ investigated for	Lymphoid Leukemiahematologic_malignancy	unknown	1	Lymphoid Leukemia	1	Curated	chembl	graph →
→ investigated for	Adult T-Cell Leukemia/Lymphomahematologic_malignancy	unknown	1	Adult T-Cell Leukemia/Lymphoma	1	Curated	chembl	graph →
→ investigated for	Fallopian Tube Neoplasmsubtype	unknown	1	Fallopian Tube Neoplasm	1	Curated	chembl	graph →
→ investigated for	Peritoneal Neoplasmcancer_family	unknown	1	Peritoneal Neoplasm	1	Curated	chembl	graph →
→ investigated for	AIDS-Related Lymphomahematologic_malignancy	unknown	1	AIDS-Related Lymphoma	1	Curated	chembl	graph →
→ investigated for	Mycosis Fungoideshematologic_malignancy	unknown	1	Mycosis Fungoides	1	Curated	chembl	graph →
→ investigated for	Sezary Syndromehematologic_malignancy	unknown	1	Sezary Syndrome	1	Curated	chembl	graph →
→ investigated for	Anaplastic Large Cell Lymphomahematologic_malignancy	unknown	1	Anaplastic Large Cell Lymphoma	1	Curated	chembl	graph →
→ investigated for	Burkitt Lymphomahematologic_malignancy	unknown	1	Burkitt Lymphoma	1	Curated	chembl	graph →
→ investigated for	Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Typehematologic_malignancy	unknown	1	Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type	1	Curated	chembl	graph →
→ investigated for	Myelodysplastic Syndromehematologic_malignancy	unknown	1	Myelodysplastic Syndrome	1	Curated	chembl	graph →
→ investigated for	Smoldering Multiple Myelomahematologic_malignancy	unknown	1	Smoldering Multiple Myeloma	1	Curated	chembl	graph →
→ investigated for	Astrocytic Tumorsubtype	unknown	1	Astrocytic Tumor	1	Curated	chembl	graph →
→ investigated for	Oligodendrogliomasubtype	unknown	1	Oligodendroglioma	1	Curated	chembl	graph →
→ investigated for	Squamous Cell Carcinomahistology	unknown	1	Squamous Cell Carcinoma	1	Curated	chembl	graph →
→ investigated for	Renal Cell Carcinomasubtype	unknown	1	Renal Cell Carcinoma	1	Curated	chembl	graph →
→ investigated for	Neuroblastomasubtype	unknown	1	Neuroblastoma	1	Curated	chembl	graph →
→ investigated for	Myeloproliferative Neoplasmhematologic_malignancy	unknown	0.5	Myeloproliferative Neoplasm	1	Curated	chembl	graph →

Bortezomib investigated for …INVESTIGATED_FOR75 of 75show fewer

→ investigated for

Mantle Cell Lymphomahematologic_malignancy

unknown

Mantle Cell Lymphoma

Curated

→ investigated for

Neoplasmcancer_family

unknown

Neoplasm

Curated

→ investigated for

Multiple Myelomahematologic_malignancy

unknown

Curated

T Acute Lymphoblastic Leukemia

→ investigated for

T Acute Lymphoblastic Leukemiahematologic_malignancy

unknown

Curated

→ investigated for

AL Amyloidosishematologic_malignancy

unknown

AL Amyloidosis

Curated

→ investigated for

Cholangiocarcinomasubtype

unknown

Cholangiocarcinoma

Curated

Waldenstrom Macroglobulinemia

→ investigated for

Waldenstrom Macroglobulinemiahematologic_malignancy

unknown

Curated

→ investigated for

Myeloid Sarcomacancer_family

unknown

Myeloid Sarcoma

Curated

→ investigated for

Non-Hodgkin Lymphomahematologic_malignancy

unknown

Non-Hodgkin Lymphoma

Curated

→ investigated for

Plasmacytomahematologic_malignancy

unknown

Plasmacytoma

Curated

Acute Lymphoblastic Leukemia

→ investigated for

Acute Lymphoblastic Leukemiahematologic_malignancy

unknown

Curated

→ investigated for

Acute Myeloid Leukemiahematologic_malignancy

unknown

Acute Myeloid Leukemia

Curated

→ investigated for

Lymphomacancer_family

unknown

Lymphoma

Curated

→ investigated for

Leukemiacancer_family

unknown

Leukemia

Curated

→ investigated for

Lung Adenocarcinomasubtype

supports

Lung Adenocarcinoma

Curated

civic

→ investigated for

Cervical Neoplasmsubtype

unknown

Cervical Neoplasm

Curated

Minimally Invasive Lung Adenocarcinoma

→ investigated for

Minimally Invasive Lung Adenocarcinomasubtype

unknown

Curated

→ investigated for

Nasopharyngeal Carcinomasubtype

unknown

Nasopharyngeal Carcinoma

Curated

→ investigated for

Uveal Melanomasubtype

unknown

Uveal Melanoma

Curated

→ investigated for

Colorectal Neoplasmsubtype

unknown

Colorectal Neoplasm

Curated

→ investigated for

Liver Neoplasmsubtype

unknown

Liver Neoplasm

Curated

→ investigated for

Paragangliomasubtype

unknown

Paraganglioma

Curated

→ investigated for

Plasma Cell Neoplasmhematologic_malignancy

unknown

Plasma Cell Neoplasm

Curated

→ investigated for

Lung Neoplasmcancer_family

unknown

Lung Neoplasm

Curated

→ investigated for

Ureter Neoplasmsubtype

unknown

Ureter Neoplasm

Curated

→ investigated for

Breast Neoplasmcancer_family

unknown

Breast Neoplasm

Curated

→ investigated for

Esophageal Neoplasmcancer_family

unknown

Esophageal Neoplasm

Curated

→ investigated for

Ovarian Neoplasmsubtype

unknown

Ovarian Neoplasm

Curated

→ investigated for

Kidney Neoplasmsubtype

unknown

Kidney Neoplasm

Curated

→ investigated for

Urethra Neoplasmsubtype

unknown

Urethra Neoplasm

Curated

→ investigated for

Gastric Neoplasmcancer_family

unknown

Gastric Neoplasm

Curated

→ investigated for

Bladder Neoplasmsubtype

unknown

Bladder Neoplasm

Curated

Central Nervous System Neoplasm

→ investigated for

Central Nervous System Neoplasmcancer_family

unknown

Curated

→ investigated for

Lung Adenocarcinomasubtype

unknown

Lung Adenocarcinoma

Curated

→ investigated for

Head and Neck Neoplasmcancer_family

unknown

Head and Neck Neoplasm

Curated

→ investigated for

Gliosarcomasubtype

unknown

Gliosarcoma

Curated

→ investigated for

Plasma Cell Leukemiahematologic_malignancy

unknown

Plasma Cell Leukemia

Curated

→ investigated for

Nasopharyngeal Neoplasmsubtype

unknown

Nasopharyngeal Neoplasm

Curated

→ investigated for

Pancreatic Neoplasmsubtype

unknown

Pancreatic Neoplasm

Curated

→ investigated for

Prostate Neoplasmsubtype

unknown

Prostate Neoplasm

Curated

Hematopoietic and Lymphoid Cell Neoplasm

→ investigated for

Hematopoietic and Lymphoid Cell Neoplasmcancer_family

unknown

Curated

→ investigated for

Sarcomacancer_family

unknown

Sarcoma

Curated

→ investigated for

Glioblastomasubtype

unknown

Glioblastoma

Curated

→ investigated for

Thyroid Gland Neoplasmsubtype

unknown

Thyroid Gland Neoplasm

Curated

Thyroid Gland Follicular Carcinoma

→ investigated for

Thyroid Gland Follicular Carcinomacancer_family

unknown

Curated

→ investigated for

Adenoid Cystic Carcinomahistology

unknown

Adenoid Cystic Carcinoma

Curated

Chronic Myeloid Leukemia, BCR-ABL1 Positive

→ investigated for

Chronic Myeloid Leukemia, BCR-ABL1 Positivemolecular_subtype

unknown

Curated

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue

→ investigated for

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissuehematologic_malignancy

unknown

Curated

Peripheral T-Cell Lymphoma, Not Otherwise Specified

→ investigated for

Peripheral T-Cell Lymphoma, Not Otherwise Specifiedhematologic_malignancy

unknown

Curated

→ investigated for

Hodgkin Lymphomahematologic_malignancy

unknown

Hodgkin Lymphoma

Curated

Chronic Lymphocytic Leukemia

→ investigated for

Chronic Lymphocytic Leukemiahematologic_malignancy

unknown

Curated

Acute Biphenotypic Leukemia

→ investigated for

Acute Biphenotypic Leukemiahematologic_malignancy

unknown

Curated

Lung Non-Small Cell Carcinoma

→ investigated for

Lung Non-Small Cell Carcinomasubtype

unknown

Curated

→ investigated for

Malignant Mesotheliomacancer_family

unknown

Malignant Mesothelioma

Curated

→ investigated for

Follicular Lymphomahematologic_malignancy

unknown

Follicular Lymphoma

Curated

Acute Promyelocytic Leukemia

→ investigated for

Acute Promyelocytic Leukemiahematologic_malignancy

unknown

Curated

→ investigated for

Melanomacancer_family

unknown

Melanoma

Curated

→ investigated for

Lymphoid Leukemiahematologic_malignancy

unknown

Lymphoid Leukemia

Curated

Adult T-Cell Leukemia/Lymphoma

→ investigated for

Adult T-Cell Leukemia/Lymphomahematologic_malignancy

unknown

Curated

→ investigated for

Fallopian Tube Neoplasmsubtype

unknown

Fallopian Tube Neoplasm

Curated

→ investigated for

Peritoneal Neoplasmcancer_family

unknown

Peritoneal Neoplasm

Curated

→ investigated for

AIDS-Related Lymphomahematologic_malignancy

unknown

AIDS-Related Lymphoma

Curated

→ investigated for

Mycosis Fungoideshematologic_malignancy

unknown

Mycosis Fungoides

Curated

→ investigated for

Sezary Syndromehematologic_malignancy

unknown

Sezary Syndrome

Curated

Anaplastic Large Cell Lymphoma

→ investigated for

Anaplastic Large Cell Lymphomahematologic_malignancy

unknown

Curated

→ investigated for

Burkitt Lymphomahematologic_malignancy

unknown

Burkitt Lymphoma

Curated

Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type

→ investigated for

Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Typehematologic_malignancy

unknown

Curated

→ investigated for

Myelodysplastic Syndromehematologic_malignancy

unknown

Myelodysplastic Syndrome

Curated

Smoldering Multiple Myeloma

→ investigated for

Smoldering Multiple Myelomahematologic_malignancy

unknown

Curated

→ investigated for

Astrocytic Tumorsubtype

unknown

Astrocytic Tumor

Curated

→ investigated for

Oligodendrogliomasubtype

unknown

Oligodendroglioma

Curated

→ investigated for

Squamous Cell Carcinomahistology

unknown

Squamous Cell Carcinoma

Curated

→ investigated for

Renal Cell Carcinomasubtype

unknown

Renal Cell Carcinoma

Curated

→ investigated for

Neuroblastomasubtype

unknown

Neuroblastoma

Curated

Myeloproliferative Neoplasm

→ investigated for

Myeloproliferative Neoplasmhematologic_malignancy

unknown

0.5

Curated

Bortezomib investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 283show all (up to 200)
→ investigated in trials for	Multiple Myelomahematologic_malignancy 372 trials (88 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Multiple Myeloma	372	Observed	clinicaltrials	graph →
→ investigated in trials for	Lymphomacancer_family 47 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Lymphoma	47	Observed	clinicaltrials	graph →
→ investigated in trials for	Mantle Cell Lymphomahematologic_malignancy 43 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Mantle Cell Lymphoma	43	Observed	clinicaltrials	graph →
→ investigated in trials for	Non-Hodgkin Lymphomahematologic_malignancy 25 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Non-Hodgkin Lymphoma	25	Observed	clinicaltrials	graph →
→ investigated in trials for	Adult Solid Neoplasm 21 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Adult Solid Neoplasm	21	Observed	clinicaltrials	graph →
→ investigated in trials for	Acute Lymphoblastic Leukemiahematologic_malignancy 19 trials (6 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Acute Lymphoblastic Leukemia	19	Observed	clinicaltrials	graph →
→ investigated in trials for	Waldenstrom Macroglobulinemiahematologic_malignancy 19 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Waldenstrom Macroglobulinemia	19	Observed	clinicaltrials	graph →
→ investigated in trials for	Leukemiacancer_family 18 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Leukemia	18	Observed	clinicaltrials	graph →
→ investigated in trials for	Acute Myeloid Leukemiahematologic_malignancy 17 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Acute Myeloid Leukemia	17	Observed	clinicaltrials	graph →
→ investigated in trials for	Lung Non-Small Cell Carcinomasubtype 15 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Lung Non-Small Cell Carcinoma	15	Observed	clinicaltrials	graph →
→ investigated in trials for	Myelodysplastic Syndromehematologic_malignancy 13 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Myelodysplastic Syndrome	13	Observed	clinicaltrials	graph →
→ investigated in trials for	Small Lymphocytic Lymphoma 13 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Small Lymphocytic Lymphoma	13	Observed	clinicaltrials	graph →
→ investigated in trials for	Follicular Lymphomahematologic_malignancy 12 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Follicular Lymphoma	12	Observed	clinicaltrials	graph →
→ investigated in trials for	Marginal Zone Lymphoma 12 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Marginal Zone Lymphoma	12	Observed	clinicaltrials	graph →
→ investigated in trials for	Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissuehematologic_malignancy 11 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue	11	Observed	clinicaltrials	graph →

Bortezomib investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 283show all (up to 200)

→ investigated in trials for

Multiple Myelomahematologic_malignancy

372 trials (88 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

372

Observed

→ investigated in trials for

Lymphomacancer_family

47 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Lymphoma

Observed

→ investigated in trials for

Mantle Cell Lymphomahematologic_malignancy

43 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Mantle Cell Lymphoma

Observed

→ investigated in trials for

Non-Hodgkin Lymphomahematologic_malignancy

25 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Non-Hodgkin Lymphoma

Observed

→ investigated in trials for

Adult Solid Neoplasm

21 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Adult Solid Neoplasm

Observed

Acute Lymphoblastic Leukemia

→ investigated in trials for

Acute Lymphoblastic Leukemiahematologic_malignancy

19 trials (6 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Observed

Waldenstrom Macroglobulinemia

→ investigated in trials for

Waldenstrom Macroglobulinemiahematologic_malignancy

19 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Observed

→ investigated in trials for

Leukemiacancer_family

18 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Leukemia

Observed

→ investigated in trials for

Acute Myeloid Leukemiahematologic_malignancy

17 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Acute Myeloid Leukemia

Observed

Lung Non-Small Cell Carcinoma

→ investigated in trials for

Lung Non-Small Cell Carcinomasubtype

15 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Observed

→ investigated in trials for

Myelodysplastic Syndromehematologic_malignancy

13 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Myelodysplastic Syndrome

Observed

Small Lymphocytic Lymphoma

→ investigated in trials for

13 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Small Lymphocytic Lymphoma

Observed

→ investigated in trials for

Follicular Lymphomahematologic_malignancy

12 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Follicular Lymphoma

Observed

→ investigated in trials for

Marginal Zone Lymphoma

12 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Marginal Zone Lymphoma

Observed

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue

→ investigated in trials for

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissuehematologic_malignancy

11 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)

—

Observed

Bortezomib studied in …STUDIED_INderived10 of 722show all (up to 200)
→ studied in	NCT07222761Phase 3 · recruiting A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM) · 722 trials list this drug (132 active)	—	—	not mapped	1	Observed	clinicaltrials	graph →
→ studied in	NCT07391657Phase 3 · recruiting A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4) · 722 trials list this drug (132 active)	—	—	Multiple Myeloma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00092222Phase 2 · active not recruiting Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity · 722 trials list this drug (132 active)	—	—	Malignant Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT04181827Phase 3 · active not recruiting A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple Myeloma · 722 trials list this drug (132 active)	—	—	Multiple Myeloma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04722146Phase 1 · active not recruiting A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma · 722 trials list this drug (132 active)	—	—	Multiple Myeloma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04133636Phase 2 · active not recruiting A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma · 722 trials list this drug (132 active)	—	—	Multiple Myeloma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04923893Phase 3 · active not recruiting A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy · 722 trials list this drug (132 active)	—	—	Multiple Myeloma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05083169Phase 3 · active not recruiting A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma · 722 trials list this drug (132 active)	—	—	Multiple Myeloma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05623020Phase 3 · recruiting A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant · 722 trials list this drug (132 active)	—	—	Multiple Myeloma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06169215Phase 2 · active not recruiting Comparing the Combination of Selinexor-Daratumumab-Velcade-Dexamethasone (Dara-SVD) With the Usual Treatment (Dara-RVD) for High-Risk Newly Diagnosed Multiple Myeloma · 722 trials list this drug (132 active)	—	—	Multiple Myeloma	1	Observed	clinicaltrials	graph →

Bortezomib studied in …STUDIED_INderived10 of 722show all (up to 200)

→ studied in

NCT07222761Phase 3 · recruiting

A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM) · 722 trials list this drug (132 active)

—

not mapped

Observed

→ studied in

NCT07391657Phase 3 · recruiting

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4) · 722 trials list this drug (132 active)

—

Observed

→ studied in

NCT00092222Phase 2 · active not recruiting

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity · 722 trials list this drug (132 active)

—

Malignant Neoplasm

Observed

→ studied in

NCT04181827Phase 3 · active not recruiting

A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple Myeloma · 722 trials list this drug (132 active)

—

Observed

→ studied in

NCT04722146Phase 1 · active not recruiting

A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma · 722 trials list this drug (132 active)

—

Observed

→ studied in

NCT04133636Phase 2 · active not recruiting

A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma · 722 trials list this drug (132 active)

—

Observed

→ studied in

NCT04923893Phase 3 · active not recruiting

A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy · 722 trials list this drug (132 active)

—

Observed

→ studied in

NCT05083169Phase 3 · active not recruiting

A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma · 722 trials list this drug (132 active)

—

Observed

→ studied in

NCT05623020Phase 3 · recruiting

A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant · 722 trials list this drug (132 active)

—

Observed

→ studied in

NCT06169215Phase 2 · active not recruiting

Comparing the Combination of Selinexor-Daratumumab-Velcade-Dexamethasone (Dara-SVD) With the Usual Treatment (Dara-RVD) for High-Risk Newly Diagnosed Multiple Myeloma · 722 trials list this drug (132 active)

—

Observed